New research conducted by the Community Pharmacy Future group (Boots UK, LloydsPharmacy, Rowlands Pharmacy and Well Pharmacy) and academics from the University of East Anglia demonstrates how community pharmacy can support patients with long-term conditions (LTCs) to improve their quality of life and provide cost effective solutions for the NHS.
Currently in England, over 15 million people are living with one or more LTC and, medicines will be the first line of their treatment in most cases.
In the second phase of their work, the Community Pharmacy Future group have delivered a new Pharmacy Care Plan (PCP) service to a large cohort of patients in West Yorkshire. The service uses validated clinical tools to support patients who have multiple LTCs, including the Patient Activation Measure (PAM®), which assesses the knowledge, skill and confidence a person has in managing their own health and health care. Research suggests that by moving from the lowest activation level to the highest, healthcare costs can be reduced by up to 21%.
The study and its results show that this new person-centred model of care empowers patients to manage their own conditions, as well as supporting the NHS self-care agenda.